Mr. Naini is currently a General Partner at Frazier Healthcare Ventures. He joined Frazier Healthcare shortly after inception in 1991 and has been a General Partner and served on the firm's management committee since 1995.

Mr. Naini leads the firm's growth equity investment practice and continues to selectively invest in late stage biopharma and medical device companies. Historically, he has been involved with several of the firm's biopharma investments, including CV Therapeutics (NASDAQ: CVTX), Tularik (NASDAQ: TLRK) and ZymoGenetics (NASDAQ: ZGEN). More recently, Mr. Naini was chairman of the board of Aspen Education Group (Aspeneducation.com) which was sold in November 2006 to Bain Capital and served on the board of CHG Healthcare Services which was sold in December 2006 to JW Childs. He currently serves on the boards of Bariatric Partners, Bravo by Elder Health, La Jolla Pharmaceuticals (NASDAQ: LJPC), Priority Solutions, ppoNEXT, Pentec Health, Inc. and ZONARE Medical Systems.

Prior to joining Frazier Healthcare, Mr. Naini was with Goldman Sachs & Co. New York. Mr. Naini received his M.B.A. from the Leonard N. Stern School of Business at New York University and a B.A. in molecular biology from the University of Pennsylvania.